FDA — authorised 27 January 2012
- Application: NDA022200
- Marketing authorisation holder: ASTRAZENECA AB
- Local brand name: BYDUREON
- Indication: FOR SUSPENSION, EXTENDED RELEASE — SUBCUTANEOUS
- Status: approved
🇺🇸 Exenatide Microspheres for Injection in United States
FDA authorised Exenatide Microspheres for Injection on 27 January 2012
Marketing authorisation
Other Diabetes approved in United States
Frequently asked questions
Is Exenatide Microspheres for Injection approved in United States?
Yes. FDA authorised it on 27 January 2012.
Who is the marketing authorisation holder for Exenatide Microspheres for Injection in United States?
ASTRAZENECA AB holds the US marketing authorisation.